ECG

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

The American College of Cardiology (ACC) and the American Heart Association (AHA) ended 2020 by publishing updated guidance on the management of valvular heart disease. This document covered significant ground with regards to transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair.

View More 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Air Pollution

Leading cardiovascular organisations call for urgent action to reduce air pollution

“Even before the COVID-19 pandemic, air pollution was an issue of growing concern due to its impact on people’s health, although it was frequently overlooked…

View More Leading cardiovascular organisations call for urgent action to reduce air pollution
Erythromycin pills

Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban

Drug Safety Update Published 17 December 2020From: Medicines and Healthcare products Regulatory Agency Erythromycin has been associated with events secondary to QT interval prolongation such…

View More Erythromycin: Caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban